Literature DB >> 21275596

Resolution of choroidal neovascularization secondary to punctate inner choroidopathy (PIC) with intravitreal anti-VEGF agents: a case series.

Simran S Mangat1, B Ramasamy, Som Prasad, Gavin Walters, Moin Mohammed, Martin Mckibbin.   

Abstract

Case series of four patients with CNVM secondary to PIC treated solely with anti VEGF in three cases and in combination with PDT in the other. This series reveals long term follow up (3 months to 28 months) which is currently not described in the literature.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21275596     DOI： 10.3109/08820538.2010.541322

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN： 0882-0538            Impact factor:   1.975


  7 in total

1.  Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy.

Authors:  T Barth; F Zeman; H Helbig; M-A Gamulescu
Journal:  Int Ophthalmol       Date:  2017-04-19       Impact factor: 2.031

2.  Intra and inter-rater agreement of inflammatory choroidal neovascular membrane measurements using optical coherence tomography angiography.

Authors:  Inês Leal; Shi Zhuan Tan; Tariq Aslam; Laura R Steeples; Nicholas P Jones; Ramandeep Chhabra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-19       Impact factor: 3.117

3.  Using spectral-domain optical coherence tomography to follow outer retinal structure changes in a patient with recurrent punctate inner choroidopathy.

Authors:  Kimberly E Stepien; Joseph Carroll
Journal:  J Ophthalmol       Date:  2011-07-10       Impact factor: 1.909

Review 4.  Punctate inner choroidopathy: a systematic review.

Authors:  Joana Campos; António Campos; Sílvia Mendes; Arminda Neves; Diana Beselga; Jp Castro Sousa
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2014

5.  Combined treatment in punctate inner choroidopathy.

Authors:  Barbara Terelak-Borys; Katarzyna Zagajewska; Irmina Jankowska-Lech; Piotr Tesla; Iwona Grabska-Liberek
Journal:  Ther Clin Risk Manag       Date:  2016-09-23       Impact factor: 2.423

6.  Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy.

Authors:  Yuting Peng; Xiongze Zhang; Lan Mi; Bing Liu; Chengguo Zuo; Miaoling Li; Feng Wen
Journal:  BMC Ophthalmol       Date:  2017-06-12       Impact factor: 2.209

7.  Punctate inner choroidopathy: a clinical case report.

Authors:  Joana Campos; António Campos; Diana Beselga; Sílvia Mendes; Arminda Neves; J P Castro Sousa
Journal:  Case Rep Ophthalmol       Date:  2013-09-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.